Please Wait
Applying Filters...
menu
    • menu
    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Data Compilation
    #PharmaFlow

    Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

    Stock Recap
    #PipelineProspector

    Menu

    Cetirizine dihydrochloride, United States Pharmacopeia (USP) Reference Standard

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 271Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    27/09/2025 Supriya Lifescience
    India
    		 SUPRIYA LIFESCIENCE LTD 39199 CETIRIZINE HYDROCHLORIDE USP 2024-02-06 Active II N/A
    27/09/2025 Seqens
    France
    		 WAVELENGTH ENTERPRISES LTD 16244 CETIRIZINE DIHYDROCHLORIDE 2002-11-14 Active II Complete 2017-03-03 2017-02-08